Search or choose
Find the right test or package.
Imatinib resistance (ABL kinase) gene analysis, also known as IRMA, is specifically designed to evaluate genetic alterations (mutations) associated with resistance to imatinib therapy in patients with certain types of cancer, particularly those with abnormalit...
Imatinib resistance (ABL kinase) gene analysis, also known as IRMA, is specifically designed to evaluate genetic alterations (mutations) associated with resistance to imatinib therapy in patients with certain types of cancer, particularly those with...
Imatinib resistance (ABL kinase) gene analysis, also known as IRMA, is specifically designed to evaluate genetic alterations (mutations) associated with resistance to imatinib therapy in patients with certain types of cancer, particularly those with abnormalities in the ABL kinase gene. Imatinib is a highly effective drug widely used for the treatment of chronic myeloid leukemia (CML), in which patients have demonstrated extremely high survival rates on imatinib treatment. However, some patients may develop resista...
Imatinib resistance (ABL kinase) gene analysis, also known as IRMA, is specifically designed to evaluate genetic alterations (mutations) associated with resistance to imatinib therapy in patients with certain types of cancer, particularly those with abnormalities in the ABL kinase gene. Imatinib is a highly effective drug widely used for the treatment of chronic myeloid leukemia (CML), in which patients have demonstrated extremely high survival rates on imatinib treatment. However, some patients may develop resista...
Find the right test or package.
Pick a convenient time.
A trained expert arrives home.
Samples move through the lab process.
Reports are delivered online.